Visby Medical Stock

PCR-Based Medical Testing

About Visby Medical Stock

Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.

Investors

Funding History

December 2012	$6.0M
January 2018	$9.5M
April 2019	$100M
February 2021	$12.3M

Management

Chief Executive Officer

Adam de la Zerda

Chief Financial Officer

Mark Ibison

Press

Visby Medical Makes Strategic Hires to Continue Business Development

prnewswire - Jun, 19 2021

Maverick Health Partners with Visby Medical to Provide and Support Rapid COVID-19 PCR Testing

businesswire - Mar, 26 2021

FDA greenlights Visby Medical's single-use, portable PCR test for COVID-19

fiercebiotech - Feb, 11 2021

Visby lands $12.3M for development of POC and consumer versions of combined rapid influenza/COVID-19 PCR test

bioworld - Feb, 2 2021

Visby Medical Speeds Development of a Rapid Flu-COVID PCR Test Designed for At-Home Use with BARDA Funding

prnewswire - Feb, 2 2021

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Request Access

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen Inc. All rights reserved.

Buy or sell Visby Medical stock pre IPO via an EquityZen fund